Abstract
Methods: We performed a retrospective analysis of 1,364 consecutive morbidly obese patients who underwent restrictive-malabsorptive Roux-en-Y gastric bypass (RYGBP) between January 1998 and December 2004. A selective use of open and laparoscopic approaches was employed since 2001. Patients were seen in the office at 1 week; 2, 3, 6, 9, 12, and 24 months; and yearly thereafter. During visits, each patient was weighed and dietary intake and exercise regimen were recorded. Results: We report a sustained weight reduction in over 90% of patients. The anastomotic leak rate was 0.15%, the 30-day readmission rate was 1.17%, and the overall mortality rate was 0.15%. Minor surgical site infection rate was 0.5%, and revision to long limb RYGBP rate was 0.07%. Conclusions: Morbid obesity represents a significant health issue. None of the medical methods of weight reduction provide a lasting weight reduction. Surgery offers the only achievable long-term solution. Although not yet universally employed, laparoscopic RYGBP is rapidly becoming the standard operation for the surgical treatment of clinically severe obesity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1359-1363 |
| Number of pages | 5 |
| Journal | Obesity Surgery |
| Volume | 18 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2008 |
| Externally published | Yes |
Fingerprint
Keywords
- Bariatric surgery
- Morbid obesity
- Outcomes
- Roux-en-Y gastric bypass
ASJC Scopus subject areas
- Surgery
- Endocrinology, Diabetes and Metabolism
- Nutrition and Dietetics
Cite this
Laparoscopic vs open gastric bypass in the management of morbid obesity : A 7-year retrospective study of 1,364 patients from a single center. / Agaba, Emmanuel Atta; Shamseddeen, Hazem; Gentles, Charmaine Victoria; Sasthakonar, Venketesh; Gellman, Larry; Gadaleta, Dominick.
In: Obesity Surgery, Vol. 18, No. 11, 01.11.2008, p. 1359-1363.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Laparoscopic vs open gastric bypass in the management of morbid obesity
T2 - A 7-year retrospective study of 1,364 patients from a single center
AU - Agaba, Emmanuel Atta
AU - Shamseddeen, Hazem
AU - Gentles, Charmaine Victoria
AU - Sasthakonar, Venketesh
AU - Gellman, Larry
AU - Gadaleta, Dominick
PY - 2008/11/1
Y1 - 2008/11/1
N2 - Methods: We performed a retrospective analysis of 1,364 consecutive morbidly obese patients who underwent restrictive-malabsorptive Roux-en-Y gastric bypass (RYGBP) between January 1998 and December 2004. A selective use of open and laparoscopic approaches was employed since 2001. Patients were seen in the office at 1 week; 2, 3, 6, 9, 12, and 24 months; and yearly thereafter. During visits, each patient was weighed and dietary intake and exercise regimen were recorded. Results: We report a sustained weight reduction in over 90% of patients. The anastomotic leak rate was 0.15%, the 30-day readmission rate was 1.17%, and the overall mortality rate was 0.15%. Minor surgical site infection rate was 0.5%, and revision to long limb RYGBP rate was 0.07%. Conclusions: Morbid obesity represents a significant health issue. None of the medical methods of weight reduction provide a lasting weight reduction. Surgery offers the only achievable long-term solution. Although not yet universally employed, laparoscopic RYGBP is rapidly becoming the standard operation for the surgical treatment of clinically severe obesity.
AB - Methods: We performed a retrospective analysis of 1,364 consecutive morbidly obese patients who underwent restrictive-malabsorptive Roux-en-Y gastric bypass (RYGBP) between January 1998 and December 2004. A selective use of open and laparoscopic approaches was employed since 2001. Patients were seen in the office at 1 week; 2, 3, 6, 9, 12, and 24 months; and yearly thereafter. During visits, each patient was weighed and dietary intake and exercise regimen were recorded. Results: We report a sustained weight reduction in over 90% of patients. The anastomotic leak rate was 0.15%, the 30-day readmission rate was 1.17%, and the overall mortality rate was 0.15%. Minor surgical site infection rate was 0.5%, and revision to long limb RYGBP rate was 0.07%. Conclusions: Morbid obesity represents a significant health issue. None of the medical methods of weight reduction provide a lasting weight reduction. Surgery offers the only achievable long-term solution. Although not yet universally employed, laparoscopic RYGBP is rapidly becoming the standard operation for the surgical treatment of clinically severe obesity.
KW - Bariatric surgery
KW - Morbid obesity
KW - Outcomes
KW - Roux-en-Y gastric bypass
UR - http://www.scopus.com/inward/record.url?scp=53849142138&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=53849142138&partnerID=8YFLogxK
U2 - 10.1007/s11695-008-9455-5
DO - 10.1007/s11695-008-9455-5
M3 - Article
C2 - 18438621
AN - SCOPUS:53849142138
VL - 18
SP - 1359
EP - 1363
JO - Obesity Surgery
JF - Obesity Surgery
SN - 0960-8923
IS - 11
ER -